MPM BioImpact’s Natera NTRA Stock Holding History

MPM BioImpact’s Portfolio NTRA Stock Details NTRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.1M	Sell	92,638 -436	-0.5%	-$93K	1.53%	25
2026 Q1	$18.6M	Sell	93,074 -477	-0.5%	-$103K	1.44%	29
2025 Q4	$21.4M	Sell	93,551 -5,373	-5%	-$1.12M	2.45%	18
2025 Q3	$15.9M	Hold	98,924	–	–	2.61%	17
2025 Q2	$16.7M	Sell	98,924 -58,123	-37%	-$9.06M	2.9%	11
2025 Q1	$22.2M	Sell	157,047 -3,579	-2%	-$575K	3.82%	7
2024 Q4	$25.4M	Sell	160,626 -16,473	-9%	-$2.4M	3.61%	5
2024 Q3	$22.5M	Buy	177,099 +2,288	+1%	+$263K	3.37%	8
2024 Q2	$18.9M	Buy	174,811 +2,398	+1%	+$244K	2.94%	8
2024 Q1	$15.8M	Buy	+172,413	New	+$13M	2.54%	10

Other funds holding NTRA

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MPM BioImpact's NTRA Position: Q2 2026 in Review

MPM BioImpact reduced its Natera (NTRA) stake by 0.47% in Q2 2026, selling an estimated $93K and leaving 92,638 shares worth $25.1M. The position accounts for 1.53% of the portfolio, ranked #25.

MPM BioImpact first reported a position in NTRA in Q1 2024 and has held it in 10 quarters since. The position peaked at $25.4M in Q4 2024. 846 funds tracked by Wall St. Rank hold NTRA as of Q2 2026.

MPM BioImpact held 92,638 shares of Natera worth $25.1M as of Q2 2026.
MPM BioImpact sold 436 Natera shares in Q2 2026, an estimated $93K.
Natera made up 1.53% of MPM BioImpact's portfolio in Q2 2026, its #25 holding.
MPM BioImpact first reported a position in Natera in Q1 2024 and has held it in 10 quarters since.
MPM BioImpact's Natera position peaked at $25.4M in Q4 2024.
846 funds tracked by Wall St. Rank held Natera as of Q2 2026.

Based on MPM BioImpact's 13F filing for Q2 2026, filed 14 Aug 2026.